# A Study of LY900014 in Participants With Type 2 Diabetes Mellitus

> **NCT03305822** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 38 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** LY900014
- **DRUG:** Insulin Lispro

## Key facts

- **NCT ID:** NCT03305822
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-11
- **Primary completion:** 2017-12-14
- **Final completion:** 2017-12-14
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2020-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03305822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03305822, "A Study of LY900014 in Participants With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03305822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*